Theories of Blood Coagulation

Although the concept of the coagulation cascade represented a significant advance in the understanding of coagulation and served for many years as a useful model, more recent clinical and experimental observations demonstrate that the cascade/waterfall hypothesis does not fully and completely reflect the events of hemostasis in vivo. The goal of this article is to review the evolution of the theories of coagulation and their proposed models to serve as a tool when reviewing the research and practice literature that was published in the context of these different theories over time.

[1]  E. Page,et al.  Plasma Throinboplastin Component (PTC) Deficiency , 1952, Journal of the American Medical Women's Association.

[2]  P. James,et al.  Genetic testing for von Willebrand disease: the Canadian experience. , 2006, Seminars in thrombosis and hemostasis.

[3]  R. Macfarlane.  An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier , 1964, Nature.

[4]  C. Owen.  A History of Blood Coagulation , 2001 .

[5]  D. Monroe,et al.  Transmission of a procoagulant signal from tissue factor‐bearing cells to platelets , 1996, Blood Coagulation and Fibrinolysis.

[6]  E. Bjørklid,et al.  Sources of tissue factor. , 2006, Seminars in thrombosis and hemostasis.

[7]  J. Sadler,et al.  New concepts in von Willebrand disease. , 2005, Annual review of medicine.

[8]  E. Davie,et al.  Waterfall Sequence for Intrinsic Blood Clotting , 1964, Science.

[9]  Maureane Hoffman,et al.  Remodeling the Blood Coagulation Cascade , 2003, Journal of Thrombosis and Thrombolysis.

[10]  D. Monroe,et al.  A Cell-based Model of Hemostasis , 2001, Thrombosis and Haemostasis.

[11]  J. Sadler.  Slippery criteria for von Willebrand disease type 1 , 2004, Journal of thrombosis and haemostasis : JTH.

[12]  R. Hoffman,et al.  Hematology: Basic Principles and Practice , 1995 .

[13]  D D Monkovic,et al.  Activation of human factor V by factor Xa and thrombin. , 1990, Biochemistry.

[14]  J. Spivak,et al.  Commentary on and reprint of von Willebrand EA, Über hereditäre Pseudohämophilie [On hereditary pseudohemophilia], in Acta Medica Scandinavica (1931) 76:521–549 , 2000 .

[15]  M. Makris,et al.  Practical Hemostasis and Thrombosis , 2008 .

[16]  Joseph Loscalzo,et al.  Thrombosis and Hemorrhage , 2002 .

[17]  H. Roberts,et al.  Oscar ratnoff: his contributions to the golden era of coagulation research , 2003, British journal of haematology.

[18]  S. Rapaport,et al.  Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. , 1998, American journal of physiology. Heart and circulatory physiology.

[19]  F. L. Taylor,et al.  The Coagulation of the Blood. Investigations on a New Clotting Factor. BY PAUL A. OWREN. Oslo, J. Christian Gundersen, 1947 , 1948 .

[20]  Dougald M Monroe,et al.  Rethinking the coagulation cascade. , 2005, Current hematology reports.

[21]  E. Willebrand.  Über hereditäre Pseudohämophilie. , 2009 .

[22]  E. Page,et al.  Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia. , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  P. Tracy,et al.  Human Coagulation Factor V Is Activated to the Functional Cofactor by Elastase and Cathepsin G Expressed at the Monocyte Surface (*) , 1995, The Journal of Biological Chemistry.

[24]  J. Cox Gill.  Diagnosis and treatment of von Willebrand disease. , 2004, Hematology/Oncology Clinics of North America.

[25]  C. Smith,et al.  Hemorrhagic disease in an infant due to deficiency of a previously undescribed clotting factor. , 1952, Blood.

[26]  J. Oliver,et al.  Active Site-inactivated Factors VIIa, Xa, and IXa Inhibit Individual Steps in a Cell-based Model of Tissue Factor-initiated Coagulation , 1998, Thrombosis and Haemostasis.

[27]  A. Patek,et al.  HEMOPHILIA. I. THE ABNORMAL COAGULATION OF THE BLOOD AND ITS RELATION TO THE BLOOD PLATELETS. , 1936, The Journal of clinical investigation.

[28]  T. Renné,et al.  Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis , 2006, The Journal of experimental medicine.

[29]  C. Hougie,et al.  Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. , 1957, The Journal of clinical investigation.

[30]  Christine A. Lee,et al.  Haemostasis: from bench to bedside , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

[31]  Macfarlane Rg,et al.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER , 1964 .

[32]  C. Hoppe,et al.  Pediatric thrombosis. , 2002, Pediatric clinics of North America.

[33]  D. Monroe,et al.  Cellular interactions in hemostasis. , 1996, Haemostasis.

[34]  K. Denson,et al.  A ‘New’ Coagulation Defect , 1956, British journal of haematology.

[35]  R. Rosenthal,et al.  New Hemophilia-like Disease Caused by Deficiency of a Third Plasma Thromboplastin Factor.∗ , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[36]  B. Dahlbäck,et al.  Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases , 2005, Journal of internal medicine.

[37]  D. Monroe,et al.  The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell‐based model of coagulation , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[38]  J. Oliver,et al.  Thrombin activates factor XI on activated platelets in the absence of factor XII. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[39]  G. Broze,et al.  The current status of coagulation. , 1995, Annals of medicine.

[40]  Claire Wilson,et al.  Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. , 1951, The Journal of clinical investigation.

[41]  A. S. Douglas,et al.  Christmas Disease , 1952 .